Ex Parte SawchukDownload PDFPatent Trial and Appeal BoardAug 5, 201612179166 (P.T.A.B. Aug. 5, 2016) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE 12/179, 166 07/24/2008 27581 7590 08/09/2016 Medtronic, Inc. (CRDM) 710 MEDTRONIC PARKWAY NE MS: LC340 Legal Patents MINNEAPOLIS, MN 55432-9924 FIRST NAMED INVENTOR Robert T. Sawchuk UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. P0023178.0l/ll l l-017US01 7662 EXAMINER PATEL, NATASHA ART UNIT PAPER NUMBER 3766 NOTIFICATION DATE DELIVERY MODE 08/09/2016 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address( es): medtronic_crdm_docketing@cardinal-ip.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte ROBERT J. SAWCHUK Appeal2013-004419 Application 12/179, 166 Technology Center 3700 Before JOHN C. KERINS, JAMES P. CAL VE, and RICHARD H. MARSCHALL, Administrative Patent Judges. KERINS, Administrative Patent Judge. DECISION ON APPEAL STATEMENT OF THE CASE Robert T. Sawchuk (Appellant) seeks our review under 35 U.S.C. § 134(a) of the Examiner's final rejection of claims 1---6, 9-23, and 26-46. Claims 7, 8, 24, and 25 are canceled. We have jurisdiction under 35 U.S.C. § 6(b ). We AFFIRM. Appeal2013-004419 Application 12/179, 166 THE INVENTION Appellant's invention is directed to a method for evaluating sensing integrity of an implantable medical device. Independent claim 1, reproduced below, is illustrative: 1. A method comprising: obtaining sensed signal information representative of a plurality of responses evoked by tissue in response to electrical stimulation of the tissue by an implantable medical device, wherein the plurality of responses are sensed at different times from one another via a same sensing vector; and evaluating sensing integrity of the implantable medical device based on analysis of the plurality of responses. THE REJECTIONS ON APPEAL The Examiner has rejected: (i) claims 1-14, 16-31, 33-38, and 40-46 under 35 U.S.C. § 103(a) as being unpatentable over Sawchuk (US 2004/0088018, published May 6, 2004); (ii) claims 14 and 31under35 U.S.C. § 103(a) as being unpatentable over Sawchuk in view of Sloman (US 6,865,422 B 1, issued Mar. 8, 2005); 1 and 1 The heading for this ground of rejection in the Final Action and in the Examiner's Answer erroneously identifies the rejection as applying to claims 15, 32, and 39. This is an obvious typographical error, in that the ensuing analysis identifies claims 14 and 31, as well as the pertinent limitations found in claims 14 and 31. Final Act. 6; Ans. 8. 2 Appeal2013-004419 Application 12/179, 166 (iii) claims 15, 32, and 39 under 35 U.S.C. § 103(a) as being unpatentable over Sawchuk in view of Dong (US 2006/0247694 Al, published Nov. 2, 2006). ANALYSIS Claims 1-14, 16--31, 33-38, and 40--46---Unpatentable over Sawchuk Appellant does not argue for the patentability of any claim separate and apart from claim 1.2 Appeal Br. 6-11. Accordingly, we will take claim 1 as representative, and the remaining claims subject to this rejection will stand or fall with claim 1. The Examiner, relying on Figure 11 of Sawchuk, finds that Sawchuk discloses all method steps set forth in claim 1, with the exception that Sawchuk does not disclose that "a plurality of responses are sensed at different times via a same vector." Final Act. 3. The Examiner additionally notes that Sawchuk is relied on for its teaching of evaluating the integrity of the sensing process. Adv. Act. 2. 3 The Examiner concludes that it would have been obvious "to make all of the measurements serially using a single vector instead of using separate parallel vectors" because a single vector "would require less hardware, such as electrodes and conductors, thereby reducing production costs." Final Act. 3. Appellant responds mainly that the Examiner's proposed modification of Sawchuk is erroneous because there would have been no apparent reason 2 Appellant includes separate subheadings for (i) claims 18-31, 33, 45, and 46; (ii) claims 34--41; and (iii) claim 42. Appeal Br. 10-11. Under each of those subheadings, Appellant refers back to the arguments presented in connection with claim 1 as the basis for seeking reversal of the rejection. 3 Advisory action dated August 30, 2012. 3 Appeal2013-004419 Application 12/179, 166 to make such a modification in Sawchuk, in particular because such a modification would render Sawchuk unsuitable for its intended purpose of being able to automatically select an optimal evoked response sensing vector, based on an evaluation of evoked response signal quality of more than one vector. Appeal Br. 6-10; Reply Br. 5-8. Appellant does not contest the Examiner's position that the proposed modification would require less hardware and reduce production costs. Even though the Examiner's proposed modification would have no need to avail itself of the automatic optimal sensing vector selection aspects of Sawchuk, as pointed out by Appellant, the proposed modification does involve the use of Sawchuk' s disclosure as to assessing the reliability or integrity of evoked responses sensed in the process. This is an intended purpose of Sawchuk as well, as it enables the further optimal sensing vector selection process.4 Rather than rendering Sawchuk unsuitable for its intended purpose, the proposed modification is seen as obtaining one advantage at the expense of losing a different feature or advantage, which does not preclude a finding of obviousness. See Medichem, S.A. v. Rolabo, S.L., 437 F.3d 1157, 1165 (Fed. Cir. 2006) ("[A] given course of action often has simultaneous advantages and disadvantages, and this does not necessarily obviate motivation to combine."). Indeed, Sawchuk explicitly recognizes that its method for selecting an optimal electrode sensing vector is applicable to "cardiac pacing systems 4 The assessment of reliability and integrity of sensed evoked responses additionally enables a determination that no sensing vector is suitable for reliable sensing of evoked responses. See, e.g., Sawchuk, Fig. 4A, steps 118, 120; Fig. 7, steps 194, 198; Fig. 9, steps 184, 198. 4 Appeal2013-004419 Application 12/179, 166 employing a lead system that provides only one possible evoked response sensing vector," for "validat[ing] the sensing vector as being reliable for capture detection." Sawchuk, para. 51. Paragraph 51 refers particularly to the process of Figure 4A, which "may be performed upon detecting loss of capture, on a periodic basis, or after receiving a manual command." Sawchuk, para. 4 7 (emphasis added). That the assessment of the reliability or integrity of the sensed evoked responses is an important aspect of the Sawchuk disclosure is further evidenced in Figure 11. See Final Act. 2-3 (relying on Figure 11 ). Steps 402 through 414 in Figure 11, in view of the attendant textual description at paragraphs 81-86, are understood as being performed iteratively using the same sensing vector, provided that "YES" determinations are made at each of steps 408 and 414. Steps 410 and 412 of that process involve evaluating sensing integrity by determining what signal quality parameters are to be assessed, and then assessing them to determine whether the signal quality is or is not acceptable. Sawchuk, Fig. 11. Paragraph 81 notes that "[ v ]erification of signal quality may be performed on a beat-by-beat basis during beat-by-beat capture verification or on a less frequent sampled basis," thus iteratively evaluating sensing integrity based on analysis of the plurality of responses. A further step of sensing vector optimization, which might result in the process switching to a different sensing vector, only occurs when "NO" determinations are made at both step 408 and step 412, or when a "NO" determination is made at step 414. Again, while having this capability is the main thrust of the Sawchuk disclosure, persons of ordinary skill in the art would readily see the desirability of employing the applicable portions of the 5 Appeal2013-004419 Application 12/179, 166 Sawchuk process even when only a single sensing vector is present. "[A] person of ordinary skill is also a person of ordinary creativity, not an automaton." KSR v. Teleflex, 550 U.S. 398, 421 (2007). The rejection of claim 1 is thus sustained based upon the Examiner's original stated grounds of rejection. Claims 2-14, 16-31, 33-38, and 40-46, not being separately argued, fall with claim 1. Although not necessary to reach our decision, we wish to address an additional issue joined between the Examiner, in the Response to Argument section of the Answer, and Appellant, in the Reply Brief. The Examiner, apparently believing Appellant's arguments to be in the nature of Sawchuk "teaching away" from the proposed modification, points to paragraphs 66, 67, 70, and 74 of Sawchuk as evidencing that a same sensing vector is used to re-run a collection of responses, with the iterative nature necessarily meaning that the responses are from different points in time. Ans. 9. Appellant responds that "the Examiner is now alleging that Sawchuk does in fact disclose a plurality of responses being sensed at different times via the same sensing vector," and that this "is entirely inconsistent with the position taken previously in [the] Final Office Action and Advisory Action." Reply Br. 6. Appellant argues that, as a result, the Examiner has failed to clearly articulate the particular differences between the claims and the Sawchuk disclosure. Id. Further, Appellant argues that, in any event, the cited portions do not disclose "evaluating sensing integrity of the implantable medical device based on analysis of the plurality of responses," as required by claim 1, but instead are directed to using the plurality of responses sensed by the same sensing vector "to identify an acceptable ER 6 Appeal2013-004419 Application 12/179, 166 sensing margin for a sensing vector for use in a pacing threshold search." Id. at 7. Although the Examiner states, in the grounds of rejection, that "Sawchuk does not disclose that a plurality of responses are sensed at different times via a same vector," the statement is made in the context of the preceding findings directed to Sawchuk disclosing the obtention of sensed signal information representative of a plurality of responses, and evaluating sensing integrity based on analysis of the plurality of responses. See, e.g., Final Act. 2-3. In other words, the Examiner's statement noting that Sawchuk does not disclose employing responses sensed at different times via "a same sensing vector," is in the context of the entire set of operative steps of the overall method of Sawchuk. 5 We thus view the Examiner's statements in the Response to Argument section of the Answer as pointing out that Sawchuk discloses instances in which a same sensing vector is used in obtaining a plurality of responses that are sensed at different times from one another, in support of the position that it would have been obvious to modify Sawchuk to employ only a single sensing vector to sense a plurality of responses in order to analyze those responses for evaluating sensing integrity. Appellant's attempt to distinguish between using the analysis of the plurality of the responses to evaluate sensing integrity, 6 as claimed, and 5 As noted above, however, the process in Figure 11 of Sawchuk, when steps 412 and 416 result in a "YES" determination, does employ responses sensed at different times via a same sensing vector. 6 Sensing integrity generally refers to the ability of the implantable device to accurately and reliably sense particular events in order to properly record 7 Appeal2013-004419 Application 12/179, 166 using the plurality of responses to identify an acceptable evoked response (ER) sensing margin for a sensing vector for use in a pacing threshold search, as disclosed in cited paragraph 66 of Sawchuk, also appears misplaced. Paragraph 66, relied on by the Examiner, is directed to an aspect of the process illustrated in Figure 7. At steps 176-178-180-184-186, an evoked response obtained using a sensing vector is analyzed to determine whether a signal-to-noise ratio and an ER sensing margin are at or above acceptable levels. Sawchuk, Fig. 7. If, at step 186, an ER sensing margin is not at or above the acceptable level, a reference sensing threshold is adjusted (generally lowered), and the test, including a pacing threshold search (see, e.g., para. 3) and the steps noted above, is repeated using a new response via the same sensing vector. Upon again reaching step 186, if the ER sensing margin is determined to be at or above the acceptable value, the sensing vector will be established as the evoked response testing vector. Sawchuk, para. 64. The sequence discussed above thus evaluates and assures the ability of the implantable device to accurately and reliably sense particular events in order to properly record such events and/or control therapy in response to sensed events, or, in other words, evaluates and assures sensing integrity. We therefore do not find the Examiner's reliance on these paragraphs in the Answer as including any flaws that would create reversible error in the rejection of claim 1 as obvious. In any event, as noted above, this analysis of this additional issue does not affect in any way our determination that the Examiner did not err in concluding that the subject matter of claim 1 is such events and/or control therapy in response to sensed events. Spec., para. 30. 8 Appeal2013-004419 Application 12/179, 166 unpatentable over Sawchuk. It is provided in order that it will be apparent that all of Appellant's arguments presented on appeal have been considered. Claims 14 and 31-- Unpatentable over Sawchuk and Sloman Appellant argues that these claims depend from one of independent claims 1, 18, and 34, and that Sloman fails to overcome the deficiencies alleged to exist in Sawchuk. Appeal Br. 11. Because we have determined above that Sawchuk is not deficient in rendering the independent claims unpatentable, this argument is not persuasive of error. The rejection of clams 14 and 31 is sustained. Claims 15, 32, and 39--Unpatentable over Sawchuk and Dong Appellant argues that these claims depend from one of independent claims 1, 18, and 34, and that Dong fails to overcome the deficiencies alleged to exist in Sawchuk. Appeal Br. 12. Because we have determined above that Sawchuk is not deficient in rendering the independent claims unpatentable, this argument is not persuasive of error. The rejection of clams 15, 32, and 39 is sustained for the reasons stated above. DECISION The rejection of claims 1-14, 16-31, 33-38, and 40-46 under 35 U.S.C. § 103(a) as being unpatentable over Sawchuk is AFFIRMED. The rejection of claims 14 and 31under35 U.S.C. § 103(a) as being unpatentable over Sawchuk in view of Sloman is AFFIRMED. The rejection of claims 15, 32, and 39 under 35 U.S.C. § 103(a) as being unpatentable over Sawchuk in view of Dong is AFFIRMED. 9 Appeal2013-004419 Application 12/179, 166 No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). AFFIRMED 10 Copy with citationCopy as parenthetical citation